Investment
Features
FeesSafety
Academy
More
Pluang+

Compare J B Hunt Transport Services Inc (JBHT) vs Johnson & Johnson (JNJ) Price & Performance

J B Hunt Transport Services IncTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

J B Hunt Transport Services Inc vs Johnson & Johnson — how do they compare? J B Hunt Transport Services Inc trades at $229.59 (market cap $21.45B), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 28.8× J B Hunt Transport Services Inc's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold J B Hunt Transport Services Inc for 46 Days and Johnson & Johnson for 129 Days on average.

JBHTJNJ
Market Cap
$21.45B$618.09B
Volume
1,028,6806,050,983
Sector
IndustrialsHealth
52-Week High
$298.41$278.43
52-Week Low
$137.09$186.00
Typical Hold Time
46 Days129 Days
Enterprise Value
$22.59B$646.37B
Dividend Yield
0.79%2.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

J B Hunt Transport Services Inc

JBHT trades at $228.91, up 2.82% today, with a bearish technical signal and neutral oscillators. The company reported revenue of $12.00B in 2025, with net income of $598.28M and a net margin of 5.31%. Recent earnings have consistently beaten estimates, but the stock faces headwinds from rising costs and multiple securities class action investigations announced in late September 2026.

The outlook is mixed: strong analyst consensus with a $289.40 price target suggests upside, but near-term risks from cost pressures and legal scrutiny cloud the picture. Earnings growth and freight demand remain key drivers, yet investor sentiment is cautious amid profit warnings and volatile diesel prices.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.

JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JBHT

No sentiment data available yet.

JNJ
82% Buy18% Sell
Avg holding period · 129 Days

Top news

Latest headlines on both assets

About J B Hunt Transport Services Inc

J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).

Read more on JBHT →

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ →